Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages

  Abu El Asrar, Ahmed M ^a   Missotten, Luc ^b   Geboes, Karel ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

CD44; Fibroblast activation protein; Hic 5; IL 13R 2; Myofibroblasts; Proliferative vitreoretinopathy; Receptor for advanced glycation end products; Snail

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; GALECTIN 3; HERMES ANTIGEN; HYDROGEN PEROXIDE INDUCIBLE CLONE 5; INTERLEUKIN 13 RECEPTOR ALPHA2; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN; SEPRASE; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL COUNT; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; EPIRETINAL MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VITREORETINOPATHY;

ACTINS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; EPIRETINAL MEMBRANE; GALECTIN 3; GELATINASES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOFIBROBLASTS; SERINE ENDOPEPTIDASES; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 79952229318     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01916.x     Document Type: Article

References (38)

1. Abu El-Asrar AM, Struyf S, Kangave D, Geboes K & Van Damme J (2006): Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 17: 155-165.
2. Abu El-Asrar AM, Van den Steen PE, Al-Amro SA, Missotten L, Opdenakker G & Geboes K (2007): Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders. Int Ophthalmol 27: 11-22. (Pubitemid 46672141)
3. Abu El-Asrar AM, Struyf S, Van Damme J & Geboes K (2008): Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 92: 699-704. (Pubitemid 351684185)
4. Acharya PS, Majumdar S, Jacob M et al. (2008): Fibroblast migration is mediated by CD44-dependent TGFβ activation. J Cell Sci 121: 1393-1402. (Pubitemid 351936304)
5. Bauer S, Jendro MC, Wadle A et al. (2006): Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther 8: R171. PMID: 17105646.
6. Boutet A, Esteban MA, Maxwell PH & Nieto MA (2007): Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis? Cell Cycle 6: 638-642.
7. Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK & Weiner LM (2002): Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 62: 4767-4772.
8. 2 - antiplasmin cleaving enzyme on collagen types I, III and IV. Arch Biochem Biophys 457: 177-186.
9. Dabiri G, Tumbarello DA, Turner CE & Van De Water L (2008a): Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-β1 autocrine loop. J Invest Dermatol 128: 2518-2525.
10. Dabiri G, Tumbarello DA, Turner CE & Van De Water L (2008b): TGF-β1 slows the growth of pathogenic myofibroblasts through a mechanisms requiring the focal adhesion protein, Hic-5. J Invest Dermatol 128: 280-291.
11. De Vriese AS, Tilton RG, Mortier S & Lameire NH (2006): Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 21: 2549-2555. (Pubitemid 44644530)
12. Fehrenback H, Weiskirchen R, Kasper M & Gressner AM (2001): Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 34: 943-952. (Pubitemid 33032029)
13. 1-dependent tissue fibrosis in chronic 2, 4, 6-trinitrobenzene sulfonic acid colitis. J Immunol 178: 5859-5870.
14. Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schitt H-J & Strober W (2008): IL-13 signaling via IL-13Rα2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 125: 2003-2013.
15. Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST & Weening JJ (2002): CD44 expression in IgA nephropathy. Am J Kidney Dis 39: 407-414.
16. Francí C, Takkunen M, Dave N et al. (2006): Expression of Snail protein in tumorstroma interface. Oncogene 25: 5134-5144. (Pubitemid 44285982)
17. Franz M, Spiegel K, Umbreit C et al. (2009): Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem Cell Biol 131: 651-660.
18. Henderson NC, Mackinnon AC, Farnworth SL et al. (2006): Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103: 5060-5065.
19. Henry LR, Lee H-O, Lee JS et al. (2007): Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 13: 1736-1741. (Pubitemid 46952939)
20. Huber MA, Kraut N, Park JC et al. (2003): Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol 120: 182-188. (Pubitemid 36513065)
21. Huebener P, Abou-Khamis T, Zymek P et al. (2008): CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol 180: 2625-2633.
22. Jakubzick C, Choi ES, Carpenter KJ et al. (2004): Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol 164: 1989-2001. (Pubitemid 38669348)
23. Lee J, Fassnacht M, Nair S, Boczkowski D & Gilboa E (2005): Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res 65: 11156-11163. (Pubitemid 41713387)
24. Lippert E, Gunckel M, Brenmoehl J et al. (2008): Regulation of galectin-3 in mucosal fibroblasts: potential role in mucosal inflammation. Clin Exp Immunol 152: 285-297. (Pubitemid 351520903)
25. Matsushita M, Yamamoto T & Nishioka K (2004): Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Int Arch Allergy Immunol 135: 348-356. (Pubitemid 40082202)
26. Messadi DV & Bertolami CN (1993): CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am J Pathol 142: 1041-1049. (Pubitemid 24060580)
27. Ostermann E, Garin-Chesa P, Heider KH et al. (2008): Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res 14: 4584-4592.
28. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ & Rettig WJ (1999): Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274: 36505-36512.
29. Pouschop KMA, Sewnath ME, Claessen N et al. (2004): CD44 deficiency increases tubular damage but reduces renal fibrosis inn obstructive nephropathy. J Am Soc Nephrol 15: 674-686. (Pubitemid 38294797)
30. Rowe RG, Li X-Y, Hu Y et al. (2009): Mesenchymal cells reactivate Snail expression to drive three-dimensional invasion programs. J Cell Biol 184: 399-408.
31. Shibanuma M, Kim-Kaneyama J, Ishino K et al. (2003): Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell 14: 1158-1171. (Pubitemid 36337460)
32. Shimamura T, Fujisawa T, Husain SR, Kioi M, Nakajima A & Puri RK (2008): Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13 R-directed cytotoxin in a rat model. J Immunol 181: 4656-4665.
33. Svee K, White J, Vaillant P et al. (1996): Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 98: 1713-1727. (Pubitemid 26359187)
34. Symeonidis C, Papakonstantinou E, Souliou E, Karakiulakis G, Dimitrakos SA & Diza E (2009): Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment. Acta Opthalmol [Epub ahead of print].
35. Wynn TA (2008): Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
36. Xia J-R, Liu N-F & Zhu N-X (2008): Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats. Int J Mol Sci 9: 638-661. (Pubitemid 351631120)
37. Yan SF, Ramasamy R, Naka Y & Schmidt AM (2003): Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93: 1159-1169. (Pubitemid 37543056)
38. Yoshizaki A, Komura K, Iwata Y et al. (2009): Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol 29: 180-189.